IRIS Accounts Production v25.1.4.42 09778473 director 1.10.23 30.9.24 30.9.24 0 0 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097784732023-09-30097784732024-09-30097784732023-10-012024-09-30097784732022-09-30097784732022-10-012023-09-30097784732023-09-3009778473ns15:EnglandWales2023-10-012024-09-3009778473ns14:PoundSterling2023-10-012024-09-3009778473ns10:Director12023-10-012024-09-3009778473ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3009778473ns10:SmallEntities2023-10-012024-09-3009778473ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3009778473ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3009778473ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3009778473ns10:AbridgedAccounts2023-10-012024-09-3009778473ns10:OrdinaryShareClass12023-10-012024-09-3009778473ns10:OrdinaryShareClass22023-10-012024-09-3009778473ns10:RegisteredOffice2023-10-012024-09-3009778473ns5:CurrentFinancialInstruments2024-09-3009778473ns5:CurrentFinancialInstruments2023-09-3009778473ns5:ShareCapital2024-09-3009778473ns5:ShareCapital2023-09-3009778473ns5:RetainedEarningsAccumulatedLosses2024-09-3009778473ns5:RetainedEarningsAccumulatedLosses2023-09-3009778473ns5:ComputerEquipment2023-10-012024-09-3009778473ns10:OrdinaryShareClass12024-09-3009778473ns10:OrdinaryShareClass22024-09-30
REGISTERED NUMBER: 09778473 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

Waendel Diagnostics Limited

Waendel Diagnostics Limited (Registered number: 09778473)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Waendel Diagnostics Limited

Company Information
for the Year Ended 30 September 2024







DIRECTOR: M J Annable





REGISTERED OFFICE: 5 Varley Close
Wellingborough
Northamptonshire
NN8 4UZ





REGISTERED NUMBER: 09778473 (England and Wales)





ACCOUNTANTS: CDA Accountancy
Unit 11/12 Hall Farm
Sywell Aerodrome
Sywell
Northamptonshire
NN6 0BN

Waendel Diagnostics Limited (Registered number: 09778473)

Abridged Balance Sheet
30 September 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 208 417

CURRENT ASSETS
Debtors 9,156 9,141
Investments 2,450 2,450
Cash at bank 18,039 13,621
29,645 25,212
CREDITORS
Amounts falling due within one year 18,795 16,389
NET CURRENT ASSETS 10,850 8,823
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,058

9,240

CAPITAL AND RESERVES
Called up share capital 5 5,000 5,000
Retained earnings 6,058 4,240
SHAREHOLDERS' FUNDS 11,058 9,240

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Waendel Diagnostics Limited (Registered number: 09778473)

Abridged Balance Sheet - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Comprehensive Income and an abridged Balance Sheet for the year ended 30 September 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 June 2025 and were signed by:





M J Annable - Director


Waendel Diagnostics Limited (Registered number: 09778473)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Waendel Diagnostics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents gross invoiced sales, including value added tax. The company operates the flat rate scheme.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

Waendel Diagnostics Limited (Registered number: 09778473)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 October 2023
and 30 September 2024 2,626
DEPRECIATION
At 1 October 2023 2,209
Charge for year 209
At 30 September 2024 2,418
NET BOOK VALUE
At 30 September 2024 208
At 30 September 2023 417

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
2,500 Ordinary A £1 2,500 2,500
2,500 Ordinary B £1 2,500 2,500
5,000 5,000